Evidence map›Paper›PMID 40870789›Full record

ArticleFoods (Basel, Switzerland)2025

Sex-Related Anti-Nociceptive Activity of a Flavonoid-Based Formulated Extract from Citrus Peels (Gold Lotion): New Insights into a Rat Model.

Alessandro Di Cerbo, Mario Nicotra, Michiko Suzawa, Tommaso Iannitti, Julio Cesar Morales-Medina

Abstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alessandro Di CerboSchool of Biosciences and Veterinary Medicine, University of Camerino, 62024 Matelica, Italy.ORCID 0000-0001-8122-9170
Mario NicotraSchool of Biosciences and Veterinary Medicine, University of Camerino, 62024 Matelica, Italy.ORCID 0009-0006-0546-9328
Michiko SuzawaMiyauchi Citrus Research Center, Shigoka-Machi, Takasaki 370-3501, Gunma, Japan.
Tommaso IannittiSection of Experimental Medicine, Department of Medical Sciences, University of Ferrara, Via Fossato di Mortara 70, 44121 Ferrara, Italy.ORCID 0000-0002-4758-0562
Julio Cesar Morales-MedinaCentro de Investigación en Reproducción Animal, Cinvestav-Universidad Autónoma de Tlaxcala, AP 62, Tlaxcala 90000, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory pain is a worldwide health problem, affecting primarily women. Nonetheless, most research conducted in this field has involved male subjects, and only 10% of the results have been obtained using females. Gold Lotion (GL) is a formulated product made from the peels of six citrus fruits that have been proven, via experimental data, to possess several biological properties, such as anti-inflammatory, anticancer, and antibacterial activities. This research aims to investigate the response to GL administration in two models of peripheral inflammation to assess potential sex differences. Carrageenan was used to induce mechanical allodynia and maximal edema within hours, serving as a model of acute inflammation, while Complete Freund's Adjuvant (CFA) was used to obtain similar results within days, resulting in a model of chronic inflammation. Acute GL administration reduced mechanical allodynia in both models and both sexes, with no anti-inflammatory effects observed. In conclusion, this study demonstrates the potential of GL to alleviate inflammatory pain in both males and females, thereby broadening its therapeutic applications.

Indexed as

carrageenanComplete Freund’s Adjuvantflavonoidinflammationmechanical allodynia

Identifiers

PMID40870789
PMCPMC12385359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.